- Home
- ACB
as 10-17-2024 4:00pm EST
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.
| Founded: | 2013 | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 315.4M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 647.8K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.50 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.84 - $9.35 | Next Earning Date: | 11-07-2024 |
| Revenue: | $203,838,819 | Revenue Growth: | 12.30% |
| Revenue Growth (this year): | 14.04% | Revenue Growth (next year): | 8.94% |
Latest Aurora Cannabis Inc. News
ACB Breaking Stock News: Dive into ACB Ticker-Specific Updates for Smart Investing
Zacks
10 hours ago
Aurora Cannabis Stock Rises Following Medical Cannabis Oil Launch
CNW Group
2 days ago
Aurora Introduces Innovative Cannabis Oil Range to Meet Diverse Patient Needs in Australia
PR Newswire
2 days ago
Aurora Introduces Innovative Cannabis Oil Range to Meet Diverse Patient Needs in Australia
Motley Fool
9 days ago
Is It Time to Load Up on Aurora Cannabis Stock?
Zacks
14 days ago
ACB Stock Likely to Gain From Genome BC-Funded Aroma Research Project
MT Newswires
16 days ago
Aurora Cannabis Down Slightly in U.S. Pre-Market After Reporting Project Collaboration Focused on Distinct Cannabis Aromas
PR Newswire
16 days ago
Aurora Cannabis Announces Collaboration on Genome BC-Funded Project Addressing Distinct Cannabis Aromas
MT Newswires
a month ago
Aurora Cannabis Appoints CEO Miguel Martin as Executive Chairman
Compare ACB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ACB Aurora Cannabis Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.